Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
April 26, 2021 at 01:53 pm EDT
Share
Guizhou Salvage Pharmaceutical Co.,Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 1,926.852 million compared to CNY 2,026.286 million a year ago. Operating income was CNY 78.667 million compared to operating loss of CNY 1,708.910 million a year ago. Net income was CNY 55.605 million compared to net loss of CNY 1,709.715 million a year ago. Basic earnings per share from continuing operations was CNY 0.0328 compared to basic loss per share from continuing operations of CNY 1.0098 a year ago.
Guizhou Chitianhua Co Ltd, formerly Guizhou Salvage Pharmaceutical Co Ltd, is a China-based company mainly engaged in chemical production and pharmaceutical production. The chemical business mainly includes the production and sales of urea, methanol and compound fertilizer. The pharmaceutical manufacturing business mainly includes the production and sales of pharmaceuticals and medical devices. The Company's pharmaceutical products include diabetes drugs, cardiovascular drugs, dermatology drugs, gynecological drugs, digestive system drugs, endocrine drugs, psychotropic drugs, among others. The Company mainly conducts businesses within the domestic market.